Endocannabinoids in the brainstem modulate dural trigeminovascular nociceptive traffic via CB1 and "Triptan" receptors: Implications in migraine

90Citations
Citations of this article
101Readers
Mendeley users who have this article in their library.

Abstract

Activation and sensitization of trigeminovascular nociceptive pathways is believed to contribute to the neural substrate of the severe and throbbing nature of pain in migraine. Endocannabinoids, as well as being physiologically analgesic, are known to inhibit dural trigeminovascular nociceptive responses. They are also involved in the descending modulation of cutaneous-evoked C-fiber spinal nociceptive responses from the brainstem. The purpose of this study was to determine whether endocannabinoids are involved in the descending modulation of dural and/or cutaneous facial trigeminovascular nociceptive responses, from the brainstem ventrolateral periaqueductal gray (vlPAG).CB1 receptor activation in the vlPAG attenuated dural-evokedA-fiber neurons (maximally by 19%) and basal spontaneous activity (maximally by 33%) in the rat trigeminocervical complex, but there was no effect on cutaneous facial receptive field responses. This inhibitory vlPAG-mediated modulation was inhibited by specificCB1 receptor antagonism, given via the vlPAG, and with a 5-HT1B/1D receptor antagonist, given either locally in the vlPAG or systemically. These findings demonstrate for the first time that brainstem endocannabinoids provide descending modulation of both basal trigeminovascular neuronal tone and A-fiber dural-nociceptive responses, which differs from the way the brainstem modulates spinal nociceptive transmission. Furthermore, our data demonstrate a novel interaction between serotonergic and endocannabinoid systems in the processing of somatosensory nociceptive information, suggesting that some of the therapeutic action of triptans may be via endocannabinoid containing neurons in the vlPAG. © 2013 the authors.

References Powered by Scopus

Ethical guidelines for investigations of experimental pain in conscious animals

7211Citations
N/AReaders
Get full text

Descending control of pain

2533Citations
N/AReaders
Get full text

Migraine - Current understanding and treatment

1658Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Pathophysiology of migraine: A disorder of sensory processing

1261Citations
N/AReaders
Get full text

Cannabis sativa: A comprehensive ethnopharmacological review of a medicinal plant with a long history

465Citations
N/AReaders
Get full text

Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science

179Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Akerman, S., Holland, P. R., Lasalandra, M. P., & Goadsby, P. J. (2013). Endocannabinoids in the brainstem modulate dural trigeminovascular nociceptive traffic via CB1 and “Triptan” receptors: Implications in migraine. Journal of Neuroscience, 33(37), 14869–14877. https://doi.org/10.1523/JNEUROSCI.0943-13.2013

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 31

62%

Researcher 12

24%

Professor / Associate Prof. 5

10%

Lecturer / Post doc 2

4%

Readers' Discipline

Tooltip

Medicine and Dentistry 22

45%

Neuroscience 13

27%

Pharmacology, Toxicology and Pharmaceut... 7

14%

Agricultural and Biological Sciences 7

14%

Article Metrics

Tooltip
Social Media
Shares, Likes & Comments: 11

Save time finding and organizing research with Mendeley

Sign up for free